Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after Fontan procedure

Artificial Organs

Volumn 32, Issue 11, 2008, Pages 864-869

  Cai, Jiming ^a   Su, Zhaokang ^a   Shi, Zhenying ^a   Zhou, Yanping ^a   Xu, Zhiwei ^a   Liu, Jinfen ^a   Chen, Ling ^a   Xu, Zhuoming ^a   Yu, Xiaoqing ^a   Ding, Wenxiang ^a   Yang, Yanmin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Congenital heart disease; Fontan operation; Milrinone; Nitric oxide; Pulmonary vascular resistance

Indexed keywords

HEMODYNAMICS; MERCURY COMPOUNDS; NITRIC OXIDE;

CONGENITAL HEART DISEASE; FONTAN OPERATION; FONTAN PROCEDURE; HAEMODYNAMICS; INHALED NITRIC OXIDE; MILRINONE; PHOSPHODIESTERASES; PULMONARY HYPERTENSION; PULMONARY VASCULAR RESISTANCE; TRANSPULMONARY PRESSURE;

BLOOD PRESSURE;

MILRINONE; NITRIC OXIDE;

ADULT; ARTERIAL GAS; ARTERIAL PRESSURE; ARTICLE; BLOOD OXYGENATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FONTAN PROCEDURE; HUMAN; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL;

EID: 55149100279     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2008.00643.x     Document Type: Article

References (23)

1. Garofalo CA, Cabreriza SE, Quinn TA, et al. Ventricular diastolic stiffness predicts perioperative morbidity and duration of pleural effusions after the Fontan operation. Circulation 2006 114 : 156 61.
2. Goldman AP, Delius RE, Deanfield JE, et al. Pharmacological control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation. Circulation 1996 94 : II44 8.
3. Gamillscheg A, Zobel G, Urlesberger B, et al. Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis. J Thorac Cardiovasc Surg 1997 113 : 435 42.
4. Khazin V, Kaufman Y, Zabeeda D, et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 2004 18 : 156 9.
5. Schulze-Neick I, Li J, Penny DJ, Redington AN. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 2001 121 : 1033 9.
6. Gao Y, Tassiopoulos AK, McGraw DJ, Hauser MC, Camporesi EM, Hakim TS. Segmental pulmonary vascular responses to changes in pH in rat lungs: role of nitric oxide. Acta Anaesthesiol Scand 1999 43 : 64 70.
7. Wynne R, Botti M. Postoperative pulmonary dysfunction in adults after cardiac surgery with cardiopulmonary bypass: clinical significance and implications for practice. Am J Crit Care 2004 13 : 384 93.
8. Ichinose F, Roberts JD Jr., Zapol, WM. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation 2004 109 : 3106 11.
9. Yoshimura N, Yamaguchi M, Oka SY, et al. Inhaled nitric oxide therapy after Fontan-type operations. Surg Today 2005 35 : 31 5.
10. Yahagi N, Kumon K, Tanigami H, et al. Inhaled nitric oxide for the postoperative management of Fontan-type operations. Ann Thorac Surg 1994 57 : 1371 3.
11. Weinberger B, Laskin DL, Heck DE, Laskin JD. The toxicology of inhaled nitric oxide. Toxicol Sci 2001 59 : 5 16.
12. Kawakami H, Ichinose F. Inhaled nitric oxide in pediatric cardiac surgery. Int Anesthesiol Clin 2004 42 : 93 100.
13. Oishi P, Grobe A, Benavidez E, et al. Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb. Am J Physiol Lung Cell Mol Physiol 2006 290 : L359 66.
14. Pearl JM, Nelson DP, Raake JL, et al. Inhaled nitric oxide increases endothelin-1 levels: a potential cause of rebound pulmonary hypertension. Crit Care Med 2002 30 : 89 93.
15. Thelitz S, Oishi P, Sanchez LS, et al. Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs. Pediatr Crit Care Med 2004 5 : 234 9.
16. Klodell CT Jr., Morey TE, Lobato EB, et al. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg 2007 83 : 68 71.
17. Giacomini M, Borotto E, Bosotti L, et al. Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDS. Anaesth Intensive Care 2007 35 : 91 3.
18. Perez-Penate G, Cabrera NP, Ponce GM, et al. Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension. Respiration 2005 72 : 419 22.
19. Minneci PC, Deans KJ, Zhi H, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005 115 : 3409 17.
20. Cogolludo A, Moreno L, Villamor E. Mechanisms controlling vascular tone in pulmonary arterial hypertension: implications for vasodilator therapy. Pharmacology 2007 79 : 65 75.
21. Bassler D, Choong K, McNamara P, Kirpalani H. Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2006 89 : 1 5.
22. Weipert J, Koch W, Haehnel JC, Meisner H. Exercise capacity and mid-term survival in patients with tricuspid atresia and complex congenital cardiac malformations after modified Fontan-operation. Eur J Cardiothorac Surg 1997 12 : 574 80.
23. Alhashemi JA, Hooper J. Treatment of milrinone-associated tachycardia with beta-blockers. Can J Anaesth 1998 45 : 67 70.